Medpace Holdings (MEDP) Net Cash Flow Growth (3y) (2018 - 2026)
Medpace Holdings (MEDP) Net Cash Flow Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | -10.07% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | -6.97% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 144.76% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 41.14% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | -26.81% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | 29.81% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 14.18% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | 4.49% |
| 10 | Medpace Holdings | 13.30 Bn | 12.64 Bn | 196.33 Mn | 106.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 106.58% |
| Dec 31, 2025 | 290.77% |
| Sep 30, 2025 | 219.52% |
| Jun 30, 2025 | -118.86% |
| Mar 31, 2025 | 15.18% |
| Dec 31, 2024 | -39.11% |
| Sep 30, 2024 | 33.75% |
| Jun 30, 2024 | 159.24% |
| Mar 31, 2024 | 42.09% |
| Dec 31, 2023 | 37.59% |
| Sep 30, 2023 | -0.84% |
| Jun 30, 2023 | -32.14% |
| Mar 31, 2023 | 77.83% |
| Dec 31, 2022 | -27.45% |
| Sep 30, 2022 | -28.67% |
| Jun 30, 2022 | -54.34% |
| Mar 31, 2022 | -279.93% |
| Dec 31, 2021 | 259.41% |
| Sep 30, 2021 | 1,078.88% |
| Jun 30, 2021 | 65.30% |